PTGS2 and hepatocellular carcinoma: Indeed, PUFAs can inhibit liver inflammation and decrease the formation of some tumorigenic factors, such as cyclooxygenase-2 (COX-2), β-catenin and tumor necrosis factor-α (TNF-α), leading to a reduction in HCC proliferation [85,86].